Skip to content
Research Article Open access CC BY 4.0

The Utility of Health and Wealth for HIV Patients on Antiretroviral Therapy in Kenya

Winnie Chacha, Jane Akinyi, Samuel Mwalili

Asian Journal of Probability and Statistics · pp. 31–38 · Published 17 Sep 2022

10.9734/ajpas/2022/v20i130481

Abstract

Aims/ Objectives: To determine the appropriate utility function that models the trade o between health and wealth for HIV/AIDS patients on Antiretroviral Therapy in Kenya. Study Design: Retrospective study. Place and Duration of Study: Jomo Kenyatta University of Agriculture and Technology, between January 2019-April 2022. Methodology: The study involved a retrospective study of 2800 patients on Antiretroviral Therapy in Kenya from the period of 2005-2017. All the records are in terms of random patient id and in no way is the privacy and anonymity of patients is compromised. The inclusion criteria is patients who had complete information on the covariates used in the model over the follow up period. The logarithmic utility function, the negative exponential utility function and the power utility function are compared using the Akaike Information Criterion to determine which one best fits the empirical data to model the health and wealth trade off of patients on Antiretroviral Therapy in Kenya. Results: Women constituted 66% of the sample. Only patients over the age of 18 years were included in the study. The mean age was 40.3. The health related quality of life values were calculated for each patient on Antiretroviral Therapy using the proxy utility function approach. The costs associated with receiving Antiretroviral Therapy treatment were obtained from simulating from a gamma distribution with ranges from existing published literature. The logarithmic utility function had the least AKaike Information Criterion. Conclusion: The marginal utility of health increases with wealth for People living with HIV and the logarithmic utility function is suitable for modelling the shape of preferences for the trade off between health and wealth for HIV patients on Antiretroviral Therapy.

Health utility wealth

References (17)

  1. 1 Methods for the Economic Evaluation of Health Care Programmes [DOI]
  2. 2 Methods for the economic evaluation of health care programmes [DOI]
  3. 3 IEEE TRANSACTIONS ON AUTOMATIC CONTROL
  4. 4 Utility approach to measuring health-related quality of life [DOI]
  5. 5 Measuring and Valuing Health Benefits for Economic Evaluation [DOI]
  6. 6 Utility Functions that Depend on Health Status: Estimates and Economic Implications
  7. 7 Fallacy of the log-normal approximation to optimal portfolio decision-making over many periods [DOI]
  8. 8 The utility of health and wealth [DOI]
  9. 9 Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs [DOI]
  10. 10 Quality-Adjusted Life Years (QALY) Utility Models under Expected Utility and Rank Dependent Utility Assumptions [DOI]
  11. 11 Weber's Law and the Biological Evolution of Risk Preferences: The Selective Dominance of the Logarithmic Utility Function, 2002 Geneva Risk Lecture [DOI]
  12. 12 Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans [DOI]
  13. 13 Donor Support and the Impacts on Health System Strengthening in Sub-Saharan Africa: Assessing the Evidence through a Review of the Literature [DOI]
  14. 14 Value for money: A utilization-focused approach to extending the foundation and contribution of economic evaluation [DOI]
  15. 15 Health Utility Estimates and Their Application to HIV Prevention in the United States: Implications for Cost-Effectiveness Modeling and Future Research Needs [DOI]
  16. 16 A New Approach to Evaluate Quality Adjusted Life Years using Proxy Utility Function - An Application to HIV/ AIDS Data [DOI]
  17. 17 Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

1

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.